Acta oto-laryngologica · 2026
Real-life outcomes and disadvantages of single radiofrequency reduction of inferior turbinate hypertrophy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Järvekülg Mario, Lilja Markus, Rosenberg Jenni, Havia Mari
Аннотация
BACKGROUND: This study analysed the long-term outcomes of single, first-time radiofrequency ablation of the inferior turbinates (RFAIT) on nasal obstruction and patient satisfaction in chronic inferior turbinate hypertrophy (ITH).
AIMS/OBJECTIVES: The primary aim was to assess RFAIT effectiveness and patient satisfaction; secondary aims included recovery and harms.
MATERIAL AND METHODS: The SNOT-22 and a specific questionnaire were sent to 165 patients who underwent their first RFAIT for nasal obstruction between June 2014 and June 2015 at the Department of Otorhinolaryngology-Head and Neck Surgery, Hyvinkää Hospital, Finland. Eligible patients had identifiable ITH and had used intranasal corticosteroids for at least three months without adequate relief. Patients with nasal polyposis, severe septal deviation, or uncorrected bleeding disorders were excluded. A total of 102 patients responded. The median follow-up was 15.2 months (range 8.0-24.2).
RESULTS: Nasal obstruction improved in 58% of patients after one RFAIT, and 75% reported a positive impact on daily life. No major postoperative complications occurred. Temporary increased obstruction, crusting, and minor bleeding were the most common complaints. Smoking and allergies had no significant effect on outcomes.
CONCLUSIONS AND SIGNIFICANCE: Single RFAIT appears to be a safe and effective outpatient treatment for chronic ITH with high patient satisfaction.
AIMS/OBJECTIVES: The primary aim was to assess RFAIT effectiveness and patient satisfaction; secondary aims included recovery and harms.
MATERIAL AND METHODS: The SNOT-22 and a specific questionnaire were sent to 165 patients who underwent their first RFAIT for nasal obstruction between June 2014 and June 2015 at the Department of Otorhinolaryngology-Head and Neck Surgery, Hyvinkää Hospital, Finland. Eligible patients had identifiable ITH and had used intranasal corticosteroids for at least three months without adequate relief. Patients with nasal polyposis, severe septal deviation, or uncorrected bleeding disorders were excluded. A total of 102 patients responded. The median follow-up was 15.2 months (range 8.0-24.2).
RESULTS: Nasal obstruction improved in 58% of patients after one RFAIT, and 75% reported a positive impact on daily life. No major postoperative complications occurred. Temporary increased obstruction, crusting, and minor bleeding were the most common complaints. Smoking and allergies had no significant effect on outcomes.
CONCLUSIONS AND SIGNIFICANCE: Single RFAIT appears to be a safe and effective outpatient treatment for chronic ITH with high patient satisfaction.